🔎 Trials Near Me

Akèy › Lupus › Distrik Columbia › Washington

Etid klinik pou Lupus nan Washington, DC

10 etid pou Lupus ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Ap rekriteFaz 3
  • Research Site, Washington D.C.
Laj 5 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05835310

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Ap rekriteEtid obsèvasyon
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda · 7 mi lwen
Laj 18 a 120 · Fanm · Mizajou Sep 28, 2026 · NCT05567198

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Ap rekriteFaz 3
  • Research Site, Silver Spring · 7 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07430306

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 18, 2026 · NCT05440422

Study of Systemic Lupus Erythematosus

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT00001372

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Ap rekriteFaz 1/2Volontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Fanm · Mizajou Jul 31, 2026 · NCT06032923

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Ap rekriteEtid obsèvasyon
  • Children's National Health System, Washington D.C.
Laj 5 a 21 · Tout sèks · Mizajou Jul 24, 2026 · NCT04833465

Lupus Landmark Study: A Prospective Registry and Biorepository

Ap rekriteEtid obsèvasyon
  • Georgetown University, Washington D.C.
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Research Accelerated by You Lupus Registry

Ap rekriteEtid obsèvasyon
  • Online Registry - No Physical Site Required, Washington D.C.
Tout laj · Tout sèks · Mizajou Jan 23, 2026 · NCT06927219

Etid Lupus nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.